Dalteparin contraindications

Dalteparin
FRAGMIN® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

• Active major bleeding
• History of heparin induced thrombocytopenia or heparin induced thrombocytopenia with thrombosis.
• Hypersensitivity to dalteparin sodium (e.g., pruritis, rash, anaphylactic reactions) [see Adverse Reactions (6.2)]
• In patients undergoing Epidural/Neuraxial anesthesia, do not administer FRAGMIN [See Boxed Warning];
  • As a treatment for unstable angina and non_q wave MI
  • For prolonged VTE prophylaxis.

• Hypersensitivity to heparin or pork products"FRAGMIN (DALTEPARIN SODIUM) INJECTION [EISAI INC.]". Retrieved 2 February 2014.